Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
To see the effect if a combination of concurrent chemoradiotherapy followed by different
adjuvant chemotherapy in treating patients with N2-3 nasopharyngeal carcinoma(NPC).